Back

Role of the cardiology pharmacist in improving quality of care for patients with acute myocardial infarction based on ESC-ACCA quality indicators

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Innovative approaches to delivering cardiovascular care Allied Professions in Cardiovascular Care ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Hasan Al Farhan

Iraqi Board for Medical Specializations, Baghdad (Iraq)

7 More presentations in this session

Presentation thumbnail
Does perceived usability of a multi-component mobile device intervention improve health-related quality of life?
Doctor D. Candelaria (Sydney, AU)
Abstract Slides Video
Presentation thumbnail
Association of 5-times sit-to-stand test with muscle weakness and prognosis in older patients with cardiovascular disease
Mr Y. Tsubaki (Sagamihara, JP)
Abstract Slides Video
Presentation thumbnail
NICE guidance in the rapid access chest pain clinic: does it work?
Ms A. Pottle (Harefield, GB)
Abstract Slides Video
Presentation thumbnail
An ACNAP survey assessing the cardiology multidisciplinary learning needs to support lipid management
Mrs A. Barrowcliff (Leeds, GB)
Abstract Slides Video
Presentation thumbnail
Differential effects of heat-not-burn, electronic cigarettes and conventional cigarettes on endothelial glycocalyx.
Doctor I. Ikonomidis (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Innovative approaches to delivering cardiovascular care

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Evaluating an integrated clinical pharmacy service model in an ambulatory cardiac clinic- a single centre study
thumbnail
Congress Presentation
Evaluating the safety and efficacy of ticagrelor vs. clopidogrel following percutaneous coronary intervention in chronic coronary disease
thumbnail
Congress Presentation
Impact of a pharmacist-led clinic in optimising lipid therapy for post-acute coronary syndromes (ACS) in high risk cardiovascular patients.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources